Annual Report Genentech • South San Francisco, CA
Providing clinical expertise and feedback regarding operational management that effectively and efficiently guides clinical trials, other studies and investigations.
Genentech
- Market Cap: $4.71 billion
- Revenue: $13.42 billion
- Industry: Chemical Manufacturing
Genentech, Inc., is a biotechnology corporation which became a subsidiary of Roche in 2009. Genentech Research and Early Development operates as an independent center within Roche. Wikipedia
Genentech, Inc., is a biotechnology corporation which became a subsidiary of Roche in 2009. Genentech Research and Early Development operates as an independent center within Roche. Wikipedia
- Market Cap: $4.71 billion
- Revenue: $13.42 billion
- Industry: Chemical Manufacturing
- Jeff''s #CancerBreakthrough was when he finally regained enough strength to play with his kids. This inspiring piece by @woes shows what this moment was like for Jeff.
- Based on a survey, only 1 in 3 women are knowledgeable about #breastcancer subtypes, which can directly impact treatment options. #BreastCancerAwareness
- ""I am optimistic about my journey with HER2-positive metastatic breast cancer. At first, I didn''t realize how serious it was and that there isn''t a cure, but with the help of my oncologist I came to understand the specifics of my diagnosis, making me feel more confident in my treatment."" Ramona, age 56, talked to us about how knowledge equals power
- When I was diagnosed with HER2-positive metastatic breast cancer, I focused on the good things in my life, like my passion for horses. My oncologist helped me understand my specific type of breast cancer and I was empowered to match my aggressive disease with an aggressive treatment regimen. - Vicki, age 58, living with HER2-positive breast cancer
Jeff''s #CancerBreakthrough was when he finally regained enough strength to play with his kids. This inspiring piece by @woes shows what this moment was like for Jeff.
Based on a survey, only 1 in 3 women are knowledgeable about #breastcancer subtypes, which can directly impact treatment options. #BreastCancerAwareness
""I am optimistic about my journey with HER2-positive metastatic breast cancer. At first, I didn''t realize how serious it was and that there isn''t a cure, but with the help of my oncologist I came to understand the specifics of my diagnosis, making me feel more confident in my treatment."" Ramona, age 56, talked to us about how knowledge equals power
When I was diagnosed with HER2-positive metastatic breast cancer, I focused on the good things in my life, like my passion for horses. My oncologist helped me understand my specific type of breast cancer and I was empowered to match my aggressive disease with an aggressive treatment regimen. - Vicki, age 58, living with HER2-positive breast cancer
